A retrospective study of low grade spindle cell lesions of the breast from a single institution, exploring diagnostic challenges, immunohistochemistry, indications for molecular testing, and limitations of biopsy assessment. #breastpath
https://t.co/oZMsFKh0lV
A comprehensive update on PEComas of the genitourinary tract, covering morphology, molecular data, risk stratification, and new classification systems. #gupath@LiangChengMD
https://t.co/jfB9qg7bmC
Grading appendiceal goblet cell adenocarcinoma is controversial. In practice it can cause difficulty for pathologists. This review documents interobserver variability and discusses the topic in detail. #gipathology https://t.co/TuVXirQyKZ
Pathological assessment of tumour beds in breast excisions post‐neoadjuvant therapy: a retrospective cohort study - Cheng - Histopathology - Wiley Online Library #openaccess#breastpath https://t.co/gR3xLu8Qoa
Continuing the story of IgG4 disease, here is a study by a group of eminent GI pathologists that explores the role of IgG4 in chronic oesophagitis with ulceration and invites us to recognise a new entity. #openaccess#GIpath https://t.co/b7IYRCKaWZ
A histological study by A. Cortot and colleagues that has important clinical implications. "Consistency of c-Met protein overexpression over time in patients with non-squamous non-small cell lung cancer" #lungpath
https://t.co/OeNYaMG5nI
An in-depth discussion of the challenges that pathologists may encounter when grading clear cell renal cell carcinoma and papillary renal cell carcinoma, with a focus on the WHO/ISUP grading system and attention to recent updates. #gupath@GladellPaner https://t.co/rD7Ok8rp0n
A distinguished group of pathologists documents the molecular profile of adenosquamous carcinoma of the gallbladder, demonstrating significant differences between this rare, aggressive tumour and adenocarcinoma. #gipathology#pathtwitter@matteo_fassan
https://t.co/Z6JBJTWyC3
A detailed review of the breast lesions that had the lowest levels of interobserver agreement in the UK NHS Screening Programme. Many were biologically borderline. The authors illustrate the pathology of several examples and explore possible solutions. https://t.co/9KOUkhON7g
FOXA1: evidence of its value as a marker for prostate cancer, including small cell carcinoma and other challenging presentations.
https://t.co/PckJEZ8ozu #GUPath#PathTwitter@JPZhaoMD
A helpful well-illustrated review by an international team of gynaecological pathologists (Drs Wong, Talia and McCluggage from Hong Kong, Australia and the UK) of a group of very rare lesions. https://t.co/ZE8u7mMVCF
Further information on a controversial IBD-related entity that has links with neoplasia: "Aberrant p53 immunohistochemical staining is uncommon in serrated epithelial change, regardless of association with dysplasia" - Bahceci et al #GIpath#Pathtwitter https://t.co/L2trtcyZD5
TERT promoter–mutated thyroid carcinomas: prognostic and histologic insights according to the WHO 2022 classification - Lee - Histopathology - Wiley Online Library https://t.co/H98ob5hNJx
Please check out this excellent review of cholangiocarcinoma by top expert Professor Yoh Zen, from Kings College Hospital, London. It summarises contemporary classification systems, molecular changes, pitfalls in interpretation, and differential diagnosis. https://t.co/EiVN5Fdsfl
Malignant vascular neoplasms of the distal female genital tract: a series of 19 cases emphasizing unusual features and diagnostic challenges - Sharma - 2026 - Histopathology - Wiley Online Library https://t.co/gzp9sKWgH9
Molecular pathology of phyllodes tumours of the breast—much more than MED12 - Pang - 2026 - Histopathology - Wiley Online Library https://t.co/fiwqij44ex